[1]赵臻,张勇.麻痹活络汤联合氯吡格雷治疗后循环脑梗死31例[J].西部中医药,2019,32(08):92-94.
 ZHAO Zhen,ZHANG Yong.Treating 31 Cases of Posterior Circulation Cerebral Infarction with Mabi Huoluo Decoction and Clopidogrel[J].Western Journal of Traditional Chinese Medicine,2019,32(08):92-94.
点击复制

麻痹活络汤联合氯吡格雷治疗后循环脑梗死31例
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年08期
页码:
92-94
栏目:
出版日期:
2019-08-15

文章信息/Info

Title:
Treating 31 Cases of Posterior Circulation Cerebral Infarction with Mabi Huoluo Decoction and Clopidogrel
文章编号:
1004-6852(2019)08-0092-03
作者:
赵臻1张勇2
1 宝鸡市陈仓医院,陕西 宝鸡 721300; 2 宝鸡市中医医院
Author(s):
ZHAO Zhen1, ZHANG Yong2
1 Baoji City Chencang Hospital, Baoji 721300, China; 2 Baoji City TCM Hospital
关键词:
后循环脑梗死麻痹活络汤氯吡格雷血清因子远期疗效
Keywords:
posterior circulation cerebral infarction Mabi Huoluo decoction clopidogrel serum factor
分类号:
R255.2
文献标志码:
B
摘要:
目的:观察麻痹活络汤联合氯吡格雷治疗后循环脑梗死的临床疗效。方法:将61例患者随机分为观察组31例和对照组30例,对照组使用氯吡格雷75 mg/次,1次/d进行治疗,观察组在对照组基础上加用麻痹活络汤治疗,2组分别于治疗前后测定血清基质金属蛋白酶9(MMP-9)、白细胞介素17(IL-17)、超敏C反应蛋白(hs-CRP)水平,评定治疗前后神经缺损评分(NIHSS)、日常生活活动能力评分(ADL)、依赖生存状态(BI)及残疾率(mRS)。结果:治疗结束后3个月内,Barthel指数、Rankin量表(mRS)评分2组比较差异有统计学意义(P<0.05)。血清MMP-9、IL-17、hs-CRP水平治疗前后2组组内比较,差异有统计学意义(P<0.05);治疗后2组组间比较差异也有统计学意义(P<0.05)。NIHSS及ADL评分治疗前后2组组内比较,差异有统计学意义(P<0.05);治疗后2组组间比较差异也有统计学意义(P<0.05)。结论:麻痹活络汤联合氯吡格雷治疗后循环脑梗死,可显著降低血清炎性因子水平,提高远期疗效。
Abstract:
Objective: To observe clinical effects of Mabi Huoluo decoction and clopidogrel in the treatment for posterior circulation cerebral infarction. Methods: All 61 patients were randomly allocated to the observation group (31 cases) and the control group (30 cases) randomly, the control group were treated with clopidogre, 75 mg each time, once each day and the observation group took Mabi Huoluo decoction on the foundation of Western medicine, to detect the levels of MMP-9, IL-17 and hs-CRP before and after treating, to assess national institute of health stroke scale (NIHSS), activity of daily living ability score (ADL), Barthel index(BI) and Rcmkin scale (mRS). Results: Within three months after treating, the difference showed statistical meaning in BZ and mRS scores between both groups (P<0.05). The difference was statistically significant in the levels of MMP-9, IL-17 and hs-CRP within two groups before and after treating (P<0.05); the difference could be found between both groups after treating (P<0.05). The difference could be found in NIHSS and ADL scores within two groups before and after treating (P<0.05), the difference was statistically significant between both groups after treating (P<0.05). Conclusion:Mabi Huoluo decoction and clopidogrel in the treatment for posterior circulation cerebral infarction could remarkably lower the levels of serum factors and lift long-term effects.

相似文献/References:

[1]包芸.通痹活络汤联合依达拉奉治疗高龄后循环脑梗死75例[J].西部中医药,2013,26(12):103.
 BAO Yun.TongBi HuoLuo Tang Combined with Edaravone in Treating 75 Cases of Senile Patients with Posterior Circulation Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2013,26(08):103.

备注/Memo

备注/Memo:
收稿日期:2018-10-22作者简介:赵臻(1981—),女,主治医师。研究方向:脑血管疾病的中西医结合治疗。
更新日期/Last Update: 2019-08-15